Victory Capital Management
PROK icon

Victory Capital Management’s ProKidney PROK Stock Holding History

Victory Capital Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,828
Closed -$21.2K – 2539
2026
Q1 		$21.2K Sell
11,828
-321
-3% -$681 ﹤0.01% 2375
2025
Q4 		$27.2K Buy
12,149
+715
+6% +$1.88K ﹤0.01% 2368
2025
Q3 		$27.7K Buy
11,434
+560
+5% +$1.49K ﹤0.01% 2381
2025
Q2 		$6.44K Sell
10,874
-205
-2% -$160 ﹤0.01% 2473
2025
Q1 		$9.71K Sell
11,079
-317
-3% -$440 ﹤0.01% 2456
2024
Q4 		$19.3K Buy
+11,396
New +$20.5K ﹤0.01% 2447

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Victory Capital Management's PROK Position: Q2 2026 in Review

Victory Capital Management sold out of ProKidney (PROK) in Q2 2026, closing a stake of 11,828 shares — an estimated $21.2K sold.

Victory Capital Management first reported a position in PROK in Q4 2024 and held it in 6 quarters. The position peaked at $27.7K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Victory Capital Management reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
  • Victory Capital Management sold 11,828 ProKidney shares in Q2 2026, an estimated $21.2K.
  • Victory Capital Management first reported a position in ProKidney in Q4 2024 and held it in 6 quarters.
  • Victory Capital Management's ProKidney position peaked at $27.7K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.